EP Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $446K | Buy |
5,379
+193
| +4% | +$16K | ﹤0.01% | 825 |
|
|
2025
Q1 | $421K | Sell |
5,186
-347
| -6% | -$28.1K | ﹤0.01% | 768 |
|
|
2024
Q4 | $498K | Buy |
5,533
+518
| +10% | +$46.6K | ﹤0.01% | 695 |
|
|
2024
Q3 | $495K | Sell |
5,015
-913
| -15% | -$90.2K | ﹤0.01% | 695 |
|
|
2024
Q2 | $550K | Sell |
5,928
-158
| -3% | -$14.6K | 0.01% | 514 |
|
|
2024
Q1 | $577K | Buy |
6,086
+478
| +9% | +$45.4K | 0.01% | 487 |
|
|
2023
Q4 | $501K | Sell |
5,608
-15,178
| -73% | -$1.36M | 0.01% | 487 |
|
|
2023
Q3 | $1.52M | Buy |
20,786
+11,832
| +132% | +$864K | 0.02% | 270 |
|
|
2023
Q2 | $1.78M | Buy |
8,954
+5,735
| +178% | +$1.14M | 0.03% | 256 |
|
|
2023
Q1 | $313K | Sell |
3,219
-2,214
| -41% | -$216K | 0.01% | 481 |
|
|
2022
Q4 | $451K | Buy |
+5,433
| New | +$451K | 0.01% | 402 |
|
|
2022
Q3 | – | Sell |
-3,179
| Closed | -$236K | – | 655 |
|
|
2022
Q2 | $236K | Buy |
3,179
+819
| +35% | +$60.8K | 0.01% | 536 |
|
|
2022
Q1 | $212K | Buy |
+2,360
| New | +$212K | ﹤0.01% | 562 |
|
|
2021
Q1 | – | Sell |
-1,361
| Closed | -$192K | – | 523 |
|
|
2020
Q4 | $192K | Buy |
+1,361
| New | +$192K | 0.01% | 419 |
|